Zero2IPO logo

Zero2IPO

Asia, Beijing, China, Beijing

Description

Zero2IPO is an integrated service provider for the venture capital and private equity industry in China.

Investor Profile

Zero2IPO has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series C (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Zero2IPO frequently co-invest with?

GB
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Maison Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
SC
North America, New York, United States, New York
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
Keyuan Industry Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Zero2IPO?

Huasai Biotechnology

Zhangjiagang, Jiangsu, China

Huasai Biotechnology develops microbial production of nucleotide-related raw materials utilizing synthetic biology technology.

BiotechnologyManufacturingPharmaceutical
Series AJan 4, 2026
Amount Raised: $14,298,174
Essentia Biosciences

Haidian, Beijing, China

Essentia Biosciences is a biotechnology company that specializes in development of cells, gene technology drugs and medical devices.

BiotechnologyGeneticsPharmaceutical
SeedJan 1, 2026
Amount Raised: $14,298,583

Hailai Technology is a biotechnology business that specializes in research and development.

BiopharmaBiotechnologyClinical TrialsLife Science
AngelDec 24, 2025
Amount Raised: $8,538,859
Hongde New Materials

Ningbo, Zhejiang, China

Hongde New Materials produces thermoplastic composite materials with fiber reinforcement.

Advanced MaterialsBuilding MaterialManufacturing
Series ASep 8, 2025
Elpiscience Biopharmaceuticals

Shanghai, Shanghai, China

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CMay 13, 2021
Amount Raised: $105,000,000

Find More Investors Like Zero2IPO

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides